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Abstract 
Background 
Diabetes mellitus is a frequent underlying comorbidity in patients with Staphylococcus 
aureus endocarditis, and it represents a risk factor for complications and a negative outcome. 
The pathogenesis of staphylococcal endocardial infections in diabetic hosts has been poorly 
characterized, and little is known about S. aureus gene expression in endocardial vegetations. 
Methods 
We utilized a rat model of experimental S. aureus endocarditis to compare the pathogenesis 
of staphylococcal infection in diabetic and nondiabetic hosts and to study the global S. aureus 
transcriptome in endocardial vegetations in vivo. 
Results 
Diabetic rats had higher levels of bacteremia and larger endocardial vegetations than 
nondiabetic control animals. Microarray analyses revealed that 61 S. aureus genes were 
upregulated in diabetic rats, and the majority of these bacterial genes were involved in amino 
acid and carbohydrate metabolism. When bacterial gene expression in vivo (diabetic or 
nondiabetic endocardial vegetations) was compared to in vitro growth conditions, higher in 
vivo expression of genes encoding toxins and proteases was observed. Additionally, genes 
involved in the production of adhesins, capsular polysaccharide, and siderophores, as well as 
amino acid and carbohydrate transport and metabolism were upregulated in endocardial 
vegetations. To test the contribution of selected upregulated genes to the pathogenesis of 
staphylococcal endocarditis, isogenic deletion mutants were utilized. A mutant defective in 
production of the siderophore staphyloferrin B was attenuated in the endocarditis model, 
whereas the virulence of a surface adhesin (ΔsdrCDE) mutant was similar to that of the 
parental S. aureus strain. 
Conclusions 
Our results emphasize the relevance of diabetes mellitus as a risk factor for infectious 
endocarditis and provide a basis for understanding gene expression during staphylococcal 
infections in vivo. 
Background 
Infective endocarditis is an invasive human disease with an estimated incidence of 5 to 16 
cases per 100,000 person-years [1,2] and an in-hospital mortality rate of 18-20% [3]. 
Staphylococcus aureus is the most frequent etiologic agent of endocarditis in developed 
countries [1,3] and is associated with an aggressive disease course, a poor outcome, and 
complications such as local destruction of valve tissue, septic emboli, and persistent 
bacteremia [3]. Antibiotic resistance is widespread among clinical S. aureus isolates, and 
bacteremia due to methicillin-resistant S. aureus (MRSA) often requires the use of expensive 
or less effective antibiotics. 
Risk factors for endocarditis include injection drug use, prosthetic heart valves, structural 
heart defects, and comorbidities, such as diabetes [2,4,5]. Among patients with endocarditis, 
S. aureus is more frequently isolated from diabetic than nondiabetic individuals [6]. 
Moreover, diabetic patients suffer from a higher mortality due to S. aureus endocarditis than 
nondiabetic patients [7]. Although defects in the immune response to bacterial infections in 
diabetic patients have been postulated [8], the mechanism(s) behind the increased 
susceptibility to invasive S. aureus infections remain elusive. 
Several S. aureus virulence factors have been implicated in the pathogenesis of endocarditis. 
Fibronectin binding protein A (FnBPA) and clumping factor A (ClfA) mediate 
staphylococcal adherence to endothelial cells [9,10]. Damage to cardiac valves results in 
exposure of the subendothelial matrix and deposition of fibrin and platelets at the site of 
endovascular injury. ClfA plays a role in S. aureus binding to platelets—an interaction that is 
critical to the induction of staphylococcal endocarditis [11]. Staphylococci recovered from 
rabbit endocardial vegetations are highly encapsulated [12]. Other factors shown to play a 
role in the pathogenesis of endocarditis include gene regulators such as sar and agr [13], 
alpha toxin [14], the sortase enzyme SrtA [15] and the proline permease PutP [16]. 
Although numerous studies have described in vivo expression of selected staphylococcal 
genes [17,18]), few have investigated overall patterns of bacterial gene expression in an 
infected host. Analyses of global gene expression patterns have focused primarily on in vitro 
conditions, and few descriptions of the S. aureus transcriptome during the course of an 
infection have been reported [19,20]. The S. aureus transcriptional profile during growth in 
broth culture correlates poorly with gene expression in mammalian infections, and further 
work to characterize S. aureus gene regulation in vivo is necessary [21]. 
Our goal was to (i) assess the impact of concurrent diabetes mellitus on the course of 
endocarditis in a well defined experimental infection model, (ii) compare the transcriptional 
profile of S. aureus in established endocardial vegetations of diabetic and nondiabetic hosts 
versus growth in vitro, and (iii) study the role of genes highly expressed in vivo as virulence 
factors in S. aureus endocarditis. 
Methods 
Bacteria and culture conditions 
To evaluate differences in endocarditis disease severity and for microarray analyses, diabetic 
or nondiabetic rats were challenged with the methicillin resistant S. aureus strain COL. To 
establish the role of selected genes in the pathogenesis of S. aureus endocarditis, we utilized 
S. aureus strain Newman and its isogenic mutants. Newman ΔsdrCDE [22] was kindly 
provided by Dr. Timothy Foster, and Newman ΔsbnE [23] was generously provided by Dr. 
David Heinrichs. Staphylococci were cultivated in tryptic soy broth (TSB) to the mid-
logarithmic phase, washed in PBS, and diluted to yield an inoculum of ~3 × 10
4
 CFU/rat. 
Rat endocarditis model 
This study was carried out in strict accordance with the recommendations in the Guide for the 
Care and Use of Laboratory Animals of the National Institutes of Health. All animal 
experiments were approved by the Harvard Medical School Standing Committee on Animals 
or by the local authorities in Regensburg. Diabetes was induced one day prior to surgery by 
injecting male Sprague-Dawley rats (~200 g; Charles River Laboratories) in the tail vein with 
streptozotocin (60 mg/kg); control rats received citrate buffer only [24]. Animals were 
considered diabetic if blood glucose levels exceeded 250 mg/dl after 24 h. 
The rat model of catheter-induced S. aureus endocarditis was described previously [25]. 
Catheterized diabetic or nondiabetic rats were challenged intravenously with ~3 × 10
4
 CFU S. 
aureus 48 h after surgery. Heparinized blood was collected daily from each animal by tail 
vein puncture and plated quantitatively. Surviving rats were euthanized on day 3 after 
challenge. Catheter tips (~2 cm) were removed, sonicated in PBS, and plated quantitatively. 
The kidneys, spleens and aortic valve vegetations were weighed, homogenized, and cultured 
quantitatively. Homogenized vegetations were pelleted, suspended in RNAprotect Bacteria 
Reagent (Qiagen) overnight at 4 °C, and stored at -80 °C. 
RNA isolation 
Total RNA was prepared from homogenized vegetation pellets from single animals after 
digestion with 4 mg/ml proteinase K (Qiagen) for 30 min. S. aureus COL cells were lysed 
with 0.5 ml zirconia silica beads (Fisher Scientific) in a dental amalgamator, and RNA was 
purified with the RNeasy Mini kit (Qiagen), treated with DNase I (Invitrogen), and stored at -
80 °C. RNA integrity and absence of eukaryotic RNA were confirmed by denaturing gel 
electrophoresis. RNA from planktonic cultures was isolated from bacteria harvested from 
mid-logarithmic (5 h) or stationary phase (18 h) TSB cultures incubated at 37 °C. 
Microarray analysis 
Ten nanograms RNA samples were amplified using ExpressArt Nanokits (Amsbio), 
according to the manufacturer’s recommendations for bacterial mRNA amplification, except 
that the final transcription and labeling step was performed using Enzo BioArray Highyield 
RNA Transcript Labeling kits to incorporate biotinylated ribonucleotides into final RNA 
products. Each biotinylated RNA sample (1 μg) was hybridized to Affymetrix S. aureus 
GeneChips following the manufacturer’s recommendations for antisense prokaryotic arrays. 
GeneChips were washed, stained, and scanned, as previously described [26]. Each condition 
(diabetic or nondiabetic rat and logarithmic- or stationary-phase culture) was analyzed in 
duplicate. GeneChip signal intensity values for each qualifier were then normalized, averaged 
and analyzed using GeneSpring 6.2 software (Silicon Genetics), as described [26]. Genes 
were considered to be induced in a vegetation if they were determined to be present by 
Affymetrix algorithms in the endocarditis condition, and if they exhibited a >2-fold increase 
in RNA titer (Student’s t-test; P ≤0.05) compared to the corresponding planktonic growth 
condition. Genes were considered down regulated in the vegetations if they were present in 
either planktonic condition and had an expression level <50% of that observed in the 
corresponding planktonic growth condition (Student’s t-test; P ≤0.05). All Genechip data 
have been deposited in the National Center for Biotechnology Information (NCBI) Gene 
Expression Omnibus (GEO) microarray repository under accession number GSE62390. 
Quantitative PCR 
cDNA was synthesized using the AffinityScript Multiple Temperature cDNA Synthesis Kit 
(Agilent Technologies), 5 μl of hot-denatured DNA-free RNA and 100 pmol of random 
hexamer primers. Products were precipitated in ethanol, resuspended in DEPC-water and 
stored at −20 °C. Quantification was performed using a LightCycler 2.0 apparatus (Roche) 
and QuantiTect SYBR Green PCR Kits (Qiagen), using 2 μl of cDNA and 20 pmol of each 
primer. Primers (Additional file 1: Table S1) were synthesized by Eurofins MWG. 
Statistical analysis 
Student’s t-tests were used to compare gene expression data. Mann–Whitney U tests were 
performed to compare quantitative culture data, and the log rank test was used to compare 
survival distributions. A P value of ≤0.05 was considered significant. 
Results 
Infective endocarditis was more severe in diabetic than nondiabetic rats 
To assess the impact of diabetes on the pathogenesis of S. aureus endocarditis induced by 
strain COL, we compared the infection in rats with streptozotocin-induced diabetes to that of 
nondiabetic rats. All rats showed increasing bacteremia levels from days 1 to 3 (Figure 1A). 
Diabetic rats had significantly higher levels of bacteremia than nondiabetic rats on days 2 and 
3 after inoculation (Figure 1A). Diabetic rats had larger endocardial vegetations (Figure 1B) 
with significantly more bacteria per vegetation (Figure 1C). We also observed trends toward 
elevated bacterial burdens in kidneys, spleens and explanted catheters from diabetic rats 
compared to nondiabetic rats (Figure 1D), although these differences did not reach statistical 
significance. 
Figure 1 Endocarditis was more severe in diabetic rats than in nondiabetic rats. (A) 
Diabetic animals had significantly higher levels of bacteremia on day 2 and day 3 after 
bacterial challenge. (B) Diabetic animals had larger vegetations, and (C) the vegetations were 
associated with a significantly higher bacterial burden. (D) The bacterial burden in the 
kidneys, spleens and catheters were not significantly different between diabetic and 
nondiabetic rats. 
Differential S. aureus gene expression in diabetic and nondiabetic rats 
We hypothesized that staphylococcal gene expression might be influenced by hyperglycemia 
in the diabetic host. Microarray analyses, however, indicated that overall gene expression was 
similar between the two groups of animals challenged with S. aureus COL. A total of 61 
transcripts were expressed higher under diabetic in vivo conditions (selected genes are 
presented in Table 1). Most of these genes were associated with metabolic processes such as 
amino acid and carbohydrate metabolism or cell homeostasis. LightCycler analyses 
confirmed higher expression of ATP synthase atpA (12.9 ± 4.3 fold) and glyceraldehyde 
dehydrogenase gapA (10.6 ± 2.1 fold) in vegetations from diabetic rats compared to 
nondiabetic rats. Only two genes (SACOL1895 and a 102 bp fragment, both with unknown 
functions) were expressed significantly lower in the vegetations of diabetic compared to 
nondiabetic animals. 
  
Table 1 List of selected genes differentially expressed in diabetic and nondiabetic 
vegetations 
Gene Diabetic vs. nondiabetic Gene product Functional group 
acpS 2.6 holo-(acyl-carrier-protein) synthase Lipid transport and metabolism 
alr 2.9 alanine racemase Cell wall/membrane biogenesis 
argG 10.0 argininosuccinate synthase Amino acid transport and metabolism 
argH 15.3 argininosuccinate lyase Amino acid transport and metabolism 
atpA 3.8 ATP synthase F1, alpha subunit Energy production and conversion 
atpE 2.4 ATP synthase F0, C subunit Energy production and conversion 
atpH 3.3 ATP synthase F1, delta subunit Energy production and conversion 
cap5F 2.5 capsular polysaccharide biosynthesis Cell wall/membrane biogenesis 
cap5K 3.5 capsular polysaccharide biosynthesis Cell wall/membrane biogenesis 
ccrB 2.0 cassette chromosome recombinase B  
dnaE 2.6 DNA polymerase III, alpha subunit Nucleotide metabolism, replication, 
recombination 
fabD 3.3 malonyl CoA-acyl carrier protein 
transacylase 
Lipid transport and metabolism 
gapA 4.4 glyceraldehyde 3-P dehydrogenase Carbohydrate transport and metabolism 
geh 2.3 glycerol ester hydrolase Miscellaneous 
glpP 2.2 glycerol uptake operon regulatory protein Transcription, translation and post-
translational mod. 
glyS 4.2 glycyl-tRNA synthetase Transcription, translation and post-
translational mod. 
hemX 2.2 hemX protein Transcription, translation and post-
translational mod. 
infB 2.6 translation initiation factor IF-2 Transcription, translation and post-
translational mod. 
kdpE 2.4 DNA-binding response regulator Regulatory 
ligA 2.3 DNA ligase, NAD-dependent Nucleotide metabolism, replication, 
recombination 
menD 2.1 carboxylic acid synthase Coenzyme transport and metabolism 
moeA 3.4 molybdopterin biosynthesis, putative Coenzyme transport and metabolism 
nrdF 2.7 ribonucleoside-diphosphate reductase 2 Nucleotide metabolism, replication, 
recombination 
pls 3.7 Plasmin sensitive protein Virulence 
recQ 2.8 ATP-dependent DNA helicase Nucleotide metabolism, replication, 
recombination 
rexA 3.2 exonuclease Nucleotide metabolism, replication, 
recombination 
ribD 2.7 riboflavin biosynthesis protein Coenzyme transport and metabolism 
ribE 2.4 riboflavin synthase, alpha subunit Coenzyme transport and metabolism 
ruvB 2.2 Holliday junction DNA helicase Nucleotide metabolism, replication, 
recombination 
sasA 4.8 LPXTG cell wall surface protein Virulence 
sirC 3.1 iron ABC transporter, permease protein Inorganic ion transport and metabolism 
ureC 7.5 urease, alpha subunit Amino acid transport and metabolism 
Differential S. aureus gene expression in endocardial vegetations 
To compare S. aureus gene expression in vivo vs. in vitro, we isolated bacterial RNA from 
endocardial vegetations on day 3 post-challenge and from staphylococci in the logarithmic or 
stationary growth phase. Overall gene expression in diabetic and nondiabetic animals was 
similar, but differences between in vivo and in vitro growth conditions tended to be more 
pronounced in vegetations from diabetic hosts (Table 2). Microarray analyses revealed that 
116 and 109 genes were expressed higher in vegetations from nondiabetic and diabetic rats, 
respectively, compared to both planktonic conditions, 98 and 103 genes were expressed 
higher in vivo compared to logarithmic phase cultures only, and 81 and 65 genes were higher 
in vivo compared to stationary phase cultures only. Additionally, we observed that 223 and 
152 genes were expressed lower under in vivo conditions in nondiabetic and diabetic animals, 
respectively, compared to both planktonic conditions, 208 and 199 genes were expressed 
lower in vivo compared to logarithmic phase cultures only, and 183 and 106 genes were 
lower in vivo compared to stationary phase cultures only. The largest group of genes 
differentially expressed in vegetations was genes of unknown function (hypothetical 
proteins). The next largest groups were genes involved in transcription, translation and 
posttranslational modification, amino acid transport and metabolism, cell wall and membrane 
biogenesis, nucleotide metabolism and replication, carbohydrate transport and metabolism, 
and virulence/immune evasion mechanisms (Figure 2). Numerous virulence-associated genes, 
such as toxins and proteases, were expressed higher in endocardial vegetations than in 
planktonic cultures. 
Table 2 Selected genes that were differentially expressed in endocardial vegetations 
Gene  Nondiabetic 
vs. log 
vegetation vs. 
stat. 
Diabetic vs. 
log 
vegetation vs. 
stat. 
Gene product 
Virulence associated genes    
hla SACOL1173 22.9 n.s. 17.5 n.s alpha-hemolysin precursor 
hld SACOL2022 38.5 n.s. 37.8 n.s. delta-hemolysin 
hlgA SACOL2419 18.5 5.4 6.3 2.1 gamma-hemolysin, component A 
hlgB SACOL2421 11.8 2.7 n.s n.s gamma hemolysin, component B 
hlgC SACOL2422 16.5 2.4 n.s n.s gamma hemolysin, component C 
lukF SACOL2004 11.1 18.7 4.9 8.1 leukocidin F subunit 
lukS SACOL2006 11.9 14.7 6.4 8.0 leukocidin S subunit 
nuc SACOL0860 n.s. n.s. 2.9 7.8 thermonuclease 
seb SACOL0907 8.0 n.s. 4.1 n.s. staphylococcal enterotoxin B 
splB SACOL1868 10.7 5.7 n.s. n.s. serine protease 
splC SACOL1867 n.s. n.s. 3.4 2.5 serine protease 
splD SACOL1866 n.s. n.s. 3.8 2.9 serine protease 
splE SACOL1865 28.4 11.6 16.9 7.5 serine protease 
aur SACOL2659 3.3 2.4 2.2 n.s. zinc metalloproteinase aureolysin 
clpB SACOL0979 n.s. n.s. 4.4 8.1 ATP-dependent protease 
ssaA SACOL2581 5.7 13.1 2.6 5.1 staphylococcal secretory antigen; 
staphyloxanthin biosynthesis protein 
sodA SACOL1610 -5.7 -4.5 -5.7 -4.5 superoxide dismutase 
Cell wall and capsule synthesis    
cap5A SACOL0136 8.5 2.8 8.8 3.0 capsular polysaccharide biosynthesis 
protein 
cap5B SACOL0137 7.3 2.6 7.4 2.6 capsular polysaccharide biosynthesis 
protein 
cap5D SACOL0139 6.3 2.2 7.4 3.8 capsular polysaccharide biosynthesis 
protein 
cap5E SACOL0140 13.4 10.2 9.1 6.8 capsular polysaccharide biosynthesis 
protein 
cap5F SACOL0141 5.3 3.6 n.s. n.s. capsular polysaccharide biosynthesis 
protein 
cap5G SACOL0142 4.3 2.5 6.6 4.0 capsular polysaccharide biosynthesis 
protein 
cap5I SACOL0144 3.3 n.s. 4.1 2.3 capsular polysaccharide biosynthesis 
protein 
cap5J SACOL0145 n.s. n.s. 2.2 2.4 capsular polysaccharide biosynthesis 
protein 
dltA SACOL0935 -8.5 -2.9 -6.2 -2.1 D-alanine-ligase subunit 1 
dltB SACOL0936 -10.8 -3.4 -9.5 -2.8 D-alanyl-lipoteichoic acid 
biosynthesis protein 
dltC SACOL0937 -4.9 n.s. -4.9 n.s. D-alanine-ligase subunit 2 
dltD SACOL0938 -13.5 -3.5 -7.4 -2.0 D-alanine transfer protein 
Surface proteins     
clfA SACOL0856 5.8 n.s. 5.6 n.s. clumping factor A 
clfB SACOL2652 n.s. n.s. n.s. 3.1 clumping factor B 
fnbA SACOL2511 3.4 2.7 n.s. n.s. fibronectin binding protein A 
sasF SACOL2668 12.2 10.5 14.4 12.9 LPXTG cell wall surface anchor 
family protein 
sdrC SACOL0519 12.3 8.7 8.6 6.5 Ser-Asp repeat protein 
pls SACOL0050 -2.3 -3.3 n.s. -4.3 surface protein 
sasA SACOL2676 n.s. -9.8 2.2 -4.2 LPXTG cell wall surface anchor 
family protein 
spa SACOL0095 -6.3 -4.9 -5.7 -4.5 immunoglobulin G binding protein 
A prec. 
iron uptake and iron regulated genes   
sbnA SACOL0112 n.s. n.s. 48.9 22.2 siderophore biosynthesis protein 
sbnB SACOL0101 n.s. n.s. 25.9 19.7 siderophore biosynthesis protein 
sbnD SACOL0103 n.s. n.s. 18.4 17.1 siderophore biosynthesis protein 
sbnE SACOL0104 n.s. n.s. 23.0 18.4 siderophore biosynthesis protein 
sbnG SACOL0106 n.s. n.s. 21.6 25.2 siderophore biosynthesis protein 
sbnH SACOL0107 n.s. n.s. 15.4 16.8 siderophore biosynthesis protein 
sbnI SACOL0108 n.s. n.s. 23.5 30.0 siderophore biosynthesis protein 
sirR SACOL0691 2.3 n.s. n.s. n.s. iron dependent repressor 
sirB SACOL0098 2.9 n.s. n.s. n.s. iron compound ABC transporter, 
permease 
 SACOL2167 n.s n.s. 2.9 n.s. iron complex transport substrate-
binding protein 
 SACOL2169 4.4 n.s. 4.2 n.s. aerobactin biosynthesis protein 
 SACOL2170 n.s. n.s. 2.6 n.s. major facilitator transporter 
transport      
isdD SACOL1142 3.1 n.s. 2.3 n.s. Heme ABC transporter 
dapF SACOL2479 18.2 18.9 15.2 15.6 diaminopimelate epimerase family 
protein 
 SACOL2478 9.2 9.4 7.8 8.3 conserved hypothetical protein 
 SACOL2477 17.6 12.8 20.9 15.1 conserved hypothetical protein 
opp1A SACOL2476 18.1 11.1 10.8 13.9 peptide ABC transporter 
opp1B SACOL2475 4.3 3.4 11.2 9.0 peptide ABC transporter, permease 
opp1C SACOL2474 15.9 12.9 30.4 24.0 peptide ABC transporter, permease 
opp1D SACOL2473 n.s. n.s. 8.0 7.3 peptide ABC transporter ATP-
binding protein 
opp1F SACOL2472 n.s. n.s. 21.5 20.9 peptide ABC transporter ATP-
binding protein 
norD SACOL2471 17.8 12.3 27.0 18.5 transporter, putative 
epiG SACOL1871 2.4 n.s. 2.6 n.s. lantibiotic ABC transporter protein 
epiE SACOL1872 4.2 n.s. 4.4 n.s. lantibiotic ABC transporter protein 
epiF SACOL1873 5.5 n.s. 5.7 n.s. lantibiotic ABC transporter protein 
malE SACOL0193 n.s. n.s. 3.1 2.5 maltose ABC transporter, maltose-
binding 
malF SACOL0194 7.4 3.9 6.0 3.5 maltose ABC transporter, permease 
protein 
malK SACOL0192 14.7 14.7 6.2 6.8 maltose ABC transporter, ATP-
binding protein 
opuD SACOL2176 2.0 2.4 n.s. n.s. osmoprotectant transporter, BCCT 
family 
tet38 SACOL0122 21.2 12.2 13.1 8.9 tetracycline resistance protein, 
putative 
ulaA SACOL0400 12.9 5.6 7.3 3.2 PTS system ascorbate-specific 
transporter 
uhpT SACOL0200 125 29 78.1 18.1 sugar phosphate antiporter 
kdpA SACOL2068 n.s. n.s. 8.5 15.0 potassium-transporting ATPase, C 
subunit 
kdpB SACOL2067 n.s. n.s. 9.0 13.3 potassium-transporting P-type 
ATPase, B unit 
norB SACOL1475 25.1 27.5 16.1 17.3 drug transporter, quinolone 
resistance protein 
 SACOL1476 24.8 22.4 18.7 18.6 transmembrane amino acid 
transporter 
ilvA SACOL1477 34.0 25.0 28.7 22.7 threonine dehydratase 
ald SACOL1478 42.3 24.0 31.2 17.6 alanine dehydrogenase 
mntH SACOL1114 -9.5 -6.3 -9.4 -6.3 Mn2+/Fe2+ transporter 
 SACOL1115 -3.9 -4.0 -4.3 -4.4 hypothetical protein 
mntC SACOL0688 3.7 -5.8 3.5 -6.3 ABC transporter substrate-binding 
protein 
mntB SACOL0689 4.1 -5.7 4.5 -4.7 ABC transporter permease 
mntA SACOL0690 8.5 -2.7 5.6 -4.4 ABC transporter ATP-binding 
protein 
 SACOL0157 -11.4 -12.0 -12.9 -12.8 conserved hypothetical protein 
 SACOL0158 -6.8 -15.2 -6.1 -13.4 ABC transporter, ATP-binding 
protein 
 SACOL0159 -6.9 -8.2 -5.0 -6.1 ABC transporter, permease protein 
 SACOL0160 -4.9 -7.1 -5.5 -7.9 conserved hypothetical protein 
metabolism      
adhE SACOL0135 22.9 22.3 30.9 31.1 alcohol dehydrogenase, iron-
containing 
ald SACOL1478 42.3 24.0 31.2 17.6 alanine dehydrogenase 
arcB1 SACOL1181 n.s. n.s. 2.2 2.5 ornithine carbamoyltransferase 
arcC SACOL1182 21.8 15.3 12.9 9.9 carbamate kinase 
arcD SACOL1183 8.7 5.9 6.8 4.8 arginine/ornithine antiporter 
arcA SACOL2657 12.4 12.2 8.4 8.5 arginine deiminase 
arcB2 SACOL2656 6.4 7.6 4.6 5.3 ornithine carbamoyltransferase 
arcD SACOL2655 30.1 43.5 27.6 43.1 arginine/ornithine antiporter 
argG SACOL0963 n.s. n.s. 3.4 6.4 argininosuccinate synthase 
argH SACOL0964 n.s. n.s. 5.4 13.3 argininosuccinate lyase 
deoB SACOL0124 4.0 2.2 4.4 2.3 phosphopentomutase 
deoD SACOL0121 7.1 7.8 8.9 10.0 purine nucleoside phosphorylase 
gltA SACOL1742 6.9 -6.7 4.8 -9.4 citrate synthase 
gntK SACOL2515 6.9 4.9 n.s. n.s. gluconokinase 
ilvA SACOL1477 34.0 25.0 28.7 22.7 threonine dehydratase 
nirB SACOL2398 21.8 19.6 12.8 11.9 nitrite reductase [NAD(P)H], large 
subunit 
nirD SACOL2397 8.1 6.1 4.7 3.9 nitrite reductase [NAD(P)H], small 
subunit 
pflA SACOL0205 94.7 125.7 116.5 157.6 pyruvate formate-lyase-activating 
enzyme 
pflB SACOL0204 44.7 46.9 59.9 65.6 formate acetyltransferase 
rbsK SACOL0253 6.9 2.5 4.9 n.s. ribokinase 
 SACOL2396 19.0 14.3 7.4 6.1 uroporphyrin-III C-methyl 
transferase 
 SACOL1476 24.8 22.4 18.7 18.6 amino acid permease 
regulators      
agrA SACOL2026 n.s. n.s. 4.8 n.s. accessory gene regulator protein A 
agrC SACOL2025 -2.6 -3.3 4.5 -2.2 accessory gene regulator protein C 
agrD SACOL2024 2.3 -4.0 5.2 n.s. accessory gene regulator protein D 
gntR SACOL2516 5.0 4.1 n.s. n.s. gluconate operon transcriptional 
repressor 
purR SACOL0539 n.s. 2.3 n.s. n.s. pur operon repressor 
rsbV SACOL2056 n.s. 3.6 n.s. 3.7 anti-anti-sigma factor RsbV 
rsbW SACOL2055 n.s. 2.7 n.s. 3.0 anti-sigma B factor 
sarA SACOL0672 n.s. 2.5 n.s. 2.1 transcriptional regulator 
sarS SACOL0096 -14.7 -7.2 -8.7 -4.2 transcriptional regulator 
sigB SACOL2054 n.s. n.s. n.s. 2.1 alternative sigma factor 
fur SACOL1541 n.s. n.s. -2.1 -3.1 transcriptional regulator, Fur family 
araC SACOL2378 -3.6 -2.7 n.s. n.s. transcriptional regulator, AraC 
family 
tetR SACOL2374 n.s. n.s. -2.0 -2.4 transcriptional regulator, TetR 
family 
vraR SACOL1942 -4.8 -3.2 -3.7 -2.5 DNA-binding response regulator 
vraS SACOL1943 -4.3 -2.8 -3.3 -2.2 sensor histidine kinase 
n.s. difference not significant. 
Figure 2 Number of genes differentially expressed in endocardial vegetations from 
nondiabetic (A) and diabetic (B) rats. Absolute number of genes down (left) or upregulated 
(right) in endocardial vegetations compared to in vitro exponential (red bars), stationary (blue 
bars), or both growth phases (black bars). The four groups with the highest number of genes 
expressed higher in vivo were amino acid transport and metabolism, carbohydrate transport 
and metabolism, virulence / immune evasion, and transcription, translation and 
posttranslational modification. 
A selection of S. aureus genes differentially expressed in endocardial vegetations compared 
to planktonic growth conditions in vitro is presented in Table 2. Among the virulence-
associated up-regulated genes were the alpha-, delta-, and gamma-hemolysins and the bi-
component leukocidins LukS and LukF, which were expressed higher under in vivo 
conditions compared to in vitro conditions. Likewise, genes encoding the metalloprotease 
aureolysin, the serine proteases SplBCDE, and the staphylococcal secretory antigen SsaA 
were all upregulated in vivo. Staphylococcal enterotoxin B (seb) showed higher expression in 
vegetations and in stationary growth phase compared to S. aureus in logarithmic growth 
phase. Neither srtA (encoding sortase A) nor putP (proline permease) showed differential 
expression in vivo. The superoxide dismutase sodA was significantly down regulated in 
endocardial vegetations compared to both in vitro conditions. 
The capsule synthesis operon (cap5A to cap5J) was expressed higher in vegetations than in 
either planktonic growth phases, whereas the dltABCD operon (encoding enzymes mediating 
D-alanylation of teichoic acids in the cell envelope) was down regulated in vivo compared to 
in vitro. Regarding the S. aureus ica locus that encodes poly-N-acetyl glucosamine, 
apparently COL does not synthesize this surface-associated polymer since it has a mutated 
icaC gene (SACOL2692). Most of the other ica genes were not expressed differentially in 
vivo or in vitro. 
Among staphylococcal surface proteins, clumping factor A (ClfA) and B (ClfB) genes were 
expressed higher in vivo compared to logarithmic or stationary growth phase planktonic 
cultures, respectively. The fibronectin binding protein A was significantly upregulated in the 
vegetations of nondiabetic rats. Genes encoding the LPXTG anchored proteins SdrC (a beta-
neurexin binding protein) and SasF (associated with resistance to linoleic acid) were up 
regulated in vivo compared to both in vitro conditions. Of note, expression of both spa 
(endoding protein A) and pls (encoding a surface-associated plasmin-sensitive protein) were 
significantly lower in vivo than in vitro. 
Regarding iron acquisition, we observed high in vivo expression of the sbn operon encoding 
proteins required for the synthesis of the nonhydroxamate siderophore staphyloferrin B. 
SbnABDEGHI were significantly upregulated in vegetations from diabetic animals compared 
to logarithmic and stationary phase planktonic cultures. The same trend and magnitude of 
changes in expression were also observed in nondiabetic vegetations, but were not considered 
statistically significant. In addition, sirB, part of the sirABC operon encoding transport of 
staphyloferrin B into the bacterial cell [23,27], showed significant up regulation in 
nondiabetic rats with endocarditis. Some of the genes encoding the siderophore staphyloferrin 
A (SACOL2167, SACOL2169, and SACOL2170 [28]) were upregulated in endocardial 
vegetations (Table 2). 
Several of the iron-regulated S. aureus genes were also involved in transport. Among the Isd 
genes that mediate heme uptake, only isdD (a heme ABC transporter) was consistently up 
regulated in vivo and only vs. logarithmic phase S. aureus. Other iron-regulated genes 
expressed significantly higher in vivo included the oligopeptide permease and norD genes of 
the opp1ABCDFnorD operon [29]. Numerous genes encoding transporters were highly 
expressed by S. aureus in endocardial vegetations. The maltose transport (malEFK) genes 
were almost uniformly upregulated in vivo by staphylococci recovered from infected 
vegetations of nondiabetic and diabetic rats. Similarly, kdpAB genes encoding a potassium-
transporting ATPase were upregulated in diabetic vegetations compared to both in vitro 
growth conditions. Other upregulated transporters include epiGEF involved in lantibiotic 
transport and tet38 and norB, mediating drug resistance. Of note, mntH (a Mn2+/Fe2+ 
transporter) was down regulated in vivo compared to both planktonic conditions, where the 
mntABC operon (involved in Mn2+ uptake, [30]) was upregulated compared to logarithmic 
phase S. aureus and down regulated compared to stationary phase cells. A large 
uncharacterized transporter operon (SACOL2471-2479) was upregulated in vivo, whereas the 
SACOL0157 to SACOL0160 operon had significantly lower expression levels in vegetations 
than in planktonic cultures. 
Genes associated with metabolic pathways and expressed higher in vegetations were 
numerous and included an alcohol dehydrogenase (adhE), nitrite reductase (nirBD), and 
genes implicated in arginine (argGH and two arc operons) and pyruvate metabolism (pflAB). 
Transcription of a few staphylococcal regulatory genes was enhanced in vivo. The 
transcriptional regulator GntR showed higher expression in vivo in nondiabetic rats. In 
contrast, genes encoding the staphylococcal accessory regulator SarS, the iron regulated 
repressor Fur, the regulators VraR and VraS, and the transcriptional regulator AraC were 
expressed lower in vivo than in vitro (Table 2). The agr locus did not show consistent 
changes in vivo compared to in vitro (Table 2), although in diabetic rats the locus was 
upregulated compared to in vitro logarithmic-phase cultures. 
Confirmation of upregulated genes in endocardial vegetations by real-time 
PCR 
We used quantitative PCR to confirm differential expression of selected genes in vivo. Genes 
were selected based on (i) upregulation in microarray analysis, (ii) being a potential virulence 
factor and (iii) not having been implicated in the pathogenesis of endocarditis previously. In 
vitro or in vivo expression of sbnC, sdrC and splB was thus quantified using the LightCycler 
real-time PCR system. Although the magnitude of the differences in gene expression varied, 
we observed an overall good correlation between gene expression measured by microarray or 
LightCycler. All three genes tested showed a trend towards higher gene expression levels in 
vivo, but only splB showed significantly higher gene expression in endocardial vegetations 
compared to both planktonic growth phases (60.4 fold upregulation versus logarithmic 
growth phase, P < 0.01, and 8.6 fold versus stationary growth phase, P = 0.03). Expression 
levels of sbnC and sdrC in endocardial vegetations were significantly higher compared to 
logarithmic growth phase S. aureus (502.3 fold for sbnC, P < 0.01, and 25.1 fold for sdrC, P 
< 0.01). 
Role of selected genes in the pathogenesis of S. aureus endocarditis 
To assess the contribution of selected genes preferentially expressed in vivo to the 
pathogenesis of S. aureus endocarditis, we performed virulence studies in the nondiabetic rat 
endocarditis model. We chose genes that had not previously been implicated as important in 
endocarditis – the sbn locus (encoding staphyloferrin B) and the sdrCDE locus (involved in 
fibrinogen-mediated S. aureus adherence to platelets under in vitro shear flow conditions 
[31]). Rats infected with Newman ΔsbnE survived longer than rats infected with the parental 
isolate (Figure 3A; P =0.047, Log-rank analysis), and they had lower bacteremia levels at all 
time points, although the differences reached significance only on day 2 (P =0.039) (Figure 
3B). Likewise, rats infected with strain Newman experienced greater weight loss (P =0.002) 
than rats infected with the sbnE mutant (Figure 3C). No significant differences were observed 
in the bacterial burden in kidneys (Figure 3D) or vegetations (Figure 3E) from rats infected 
with Newman or the ΔsbnE mutant. In contrast, rats infected with strain Newman or the 
ΔsdrCDE mutant had similar survival times (not shown), bacteremia levels (Additional file 1: 
Figure S1A), and weight loss (Additional file 1: Figure S1B). Likewise, the bacterial burdens 
in the kidneys (Additional file 1: Figure S1C) and endocardial vegetations (Additional file 1: 
Figure S1D) were comparable for wild type and ΔsdrCDE strains. 
Figure 3 Comparative virulence of strain Newman and its isogenic sbnE deletion 
mutant. (A) Compared to rats infected with strain Newman, rats infected with the sbnE 
mutant (defective in the synthesis of the siderophore staphyloferrin B) lived significantly 
longer than rats infected with the parental strain, (B) had significantly lower levels of 
bacteremia on day 2, and (C) lost significantly less weight 48 h after bacterial inoculation. 
(D) Bacterial burdens in the kidneys and (E) vegetations were not significantly different 
between wild type and mutant strain. 
Discussion 
Diabetic patients have a higher risk of staphylococcal infections than nondiabetic hosts, and 
diabetic patients who develop S. aureus infective endocarditis are likely to experience a poor 
outcome [2,5]. We have demonstrated in an animal model of S. aureus endocarditis that 
diabetes is associated with a more severe disease course, as reflected by higher levels of 
bacteremia and larger endocardial vegetations. We used the vegetations recovered from 
infected rats on infection day 3 to investigate the in vivo transcriptome of S. aureus in the 
setting of an acute infection. This time point allowed maximal recovery of organisms 
multiplying within the host and allowed us to recover sufficient bacterial RNA for analysis. 
Characterization of gene regulation and gene expression under in vivo conditions is a 
prerequisite for alternative treatment approaches, including the development of new drug 
targets and vaccination strategies. The S. aureus transcriptome under in vivo conditions has 
not been well characterized. Global S. aureus gene expression in vitro has been investigated 
after in vitro exposure to microbicides [32], in response to mild acid [33], during growth in 
biofilm [34], in blood [35] and after phagocytosis [36]. Changes in S. aureus gene expression 
during early adaptation to the mouse lung were described [19], and Date et al. recently 
reported global S. aureus gene expression in human abscesses and infected murine kidneys 
[20]. Our study is the first description of the S. aureus transcriptome during an established 
endocardial infection. We used rich medium (TSB) as an in vitro comparator condition, 
although minimal medium such as RPMI may better reflect iron-limited conditions in vivo. 
The choice of TSB as the in vitro comparator medium may explain some of the differences in 
gene expression reported (e.g. iron rich medium versus iron depleted in vivo conditions). 
However, one of the aims of our study was to compare the gene expression pattern observed 
in endocarditis vegetations to gene expression found during growth under standard laboratory 
conditions. Our approach thus ensures comparability to previously published in vitro data 
(including previous microarray data, e.g. [26,36-38]) and highlights the important 
contribution of in vivo conditions (e.g. iron starvation) to S. aureus gene expression during an 
infection. An additional limitation of our study is the lack of a glucose supplemented in vitro 
control arm. However, the fact that we did not observe significant differences in S. aureus 
virulence gene expression between nondiabetic and diabetic rats makes this additional control 
less important. 
S. aureus COL is a well defined and sequenced MRSA strain that we used for the 
experiments with diabetic vs. nondiabetic rats and the microarray analyses. Moreover, all 
gene expression studies and subsequent analyses were performed with strain COL. A related 
MSSA strain (Newman [39]) was used for the single gene knockout studies because of the 
availability of relevant mutant strains. Mutations in strains Newman and COL have been 
described [40-42], and both strains are members of clonal complex 8 and readily produce 
endocarditis in rats. 
We observed that >100 genes were upregulated in endocardial vegetations compared to in 
vitro cultures. However, the number of genes significantly down regulated in vivo was 
approximately two-fold higher than the number of genes upregulated in vivo. This may be 
due to the fact that in vivo S. aureus gene expression was analyzed from vegetations three 
days after bacterial challenge. Date et al. [20] reported similar gene expression patterns in 
human abscesses and infected murine kidneys for some S. aureus genes such as the serine 
proteases spl, gamma-hemolysin and the opp1 operon. Other genes with higher expression 
levels in abscesses such as the isd genes, however, were not differentially expressed in 
endocardial vegetations in our study. 
A majority of the genes that were differentially expressed in endocardial vegetations have not 
yet been assigned a function or are classified as hypothetical proteins. ClfA is a critical 
virulence factor in S. aureus endocarditis [10] and clfA transcript levels have been reported to 
increase after the late log growth phase in vitro [43]. In our study, clfA was upregulated in 
vivo versus logarithmic growth phase cells, whereas fibronectin binding protein A was found 
to be significantly upregulated in nondiabetic vegetations only. Both are likely to be critical 
for initiation of infection, as has been described in previous studies [44,45]. Although 
acapsular strains provoke endocarditis at lower inocula than encapsulated isolates [46], S. 
aureus recovered from vegetations were shown to produce large quantities of capsular 
polysaccharides [12], consistent with our observation that the cap5 genes were upregulated in 
established vegetations. Capsule production enhances bacteremia in vivo and renders the 
bacterium resistant to uptake and killing by neutrophils [47]. Moreover, active and/or passive 
immunization strategies targeting capsular polysaccharides were able to protect rodents 
against S. aureus bacteremia [48] and endocarditis [25]. In contrast to the cap5 genes, the dlt 
operon was down regulated in endocardial vegetations. The dlt genes encode proteins 
mediating D-alanylation of lipoteichoic and wall teichoic acids, and transcription of the dlt 
genes is repressed in the presence of cations such as magnesium salt [49]. Higher dlt 
expression has been associated with daptomycin resistance [50], and the observation that dlt 
is down regulated in endocardial vegetations could thus support clinical and preclinical data 
on the use of daptomycin in staphylococcal endocarditis [51,52]. 
Other virulence factors upregulated in vivo include exotoxins (hemolysins and leukotoxins) 
and proteases. The serine protease genes splA – splE are located on a pathogenicity island 
[39], and these proteases play a role in the degradation and inactivation of antibacterial 
peptides [53]. Both Spl proteases and aureolysin (aur) are associated with detachment of S. 
aureus from established biofilms [54] and may promote bacteremia by dispersing 
staphylococci from endocardial vegetations. Exotoxins upregulated in endocardial 
vegetations include two-component pore-forming cytolysins such as gamma-hemolysin and 
LukFS that are able to lyse erythrocytes and leukocytes [55]. Other factors previously 
implicated in the pathogenesis of endocarditis such as the sortase enzyme SrtA [15] and the 
proline permease PutP [16] were not differentially expressed in endocardial vegetations 
compared to planktonic conditions. 
To acquire iron from the host organism, S. aureus synthesizes two major nonhydroxamate 
siderophores (staphyloferrin A and staphyloferrin B [28,56]), as well as proteins that mediate 
import and utilization of iron bound to heme or transferrin [57]. Although heme was 
identified as a preferred iron source for S. aureus [57], we found neither the iron surface 
determinant (isd) nor the heme transport system (hts) genes significantly upregulated in 
endocardial vegetations (with the exception of isdD compared to exponential phase cultures). 
In contrast, the staphyloferrin B synthesis operon (sbnA – sbnI) was preferentially 
upregulated in vivo. There was also a trend towards higher expression in vivo of the fhuCBG 
operon encoding an ABC transporter for iron(III)-hydroxamates [58]. However, fhuD1 and 
fhuD2, encoding iron(III)-hydroxamate-binding lipoproteins, were not upregulated in 
endocarditis (not shown). The observed differences in iron uptake systems may in part be 
attributable to different experimental conditions and the animal models employed (e.g. [59]). 
Dale et al. [23] constructed a Newman mutant (ΔsbnE) deficient in staphyloferrin B 
synthesis, and introduction of sbnE on a plasmid complemented the inability of the mutant to 
produce the siderophore under iron-limiting conditions. The Newman ΔsbnE mutant was 
compromised in the S. aureus renal abscess model [23]. The Newman ΔsbnE was attenuated 
in the endocarditis model since rats inoculated with the mutant showed lower bacteremia 
levels, reduced weight loss and increased survival compared to animals challenged with the 
parental strain. Although the reduction in virulence is modest, this can likely be attributed to 
the multitude of virulence factors involved in the pathogenesis of staphylococcal 
endocarditis. Thus, staphyloferrin B appears to promote staphylococcal virulence in abscesses 
and endocarditis. 
Genes encoding multiple transporters were highly expressed in endocardial vegetations, 
including amino acid permeases, the lantibiotic transporter proteins EpiEFG, a maltose 
transporter, a potassium ATPase, the norD-opp1 operon and genes associated with drug 
resistance such as tet38 and norB. NorB promoted bacterial survival in a subcutaneous 
abscess model [17], and it has broad substrate specificity. Upregulation of norB under 
conditions of low pH or reduced aeration has been reported [60]. Similarly, the efflux pump 
transporter NorD is iron-regulated and highly expressed in staphylococcal abscesses [29]. 
NorD is part of an operon with five upstream oligopeptide permease genes (opp1ABCDF), 
and all were significantly upregulated in endocardial vegetations. NorB and NorD efflux 
pumps may eliminate toxic metabolites or antibacterial factors produced by the host in vivo, 
although their substrates remain to be defined. 
Among the surface molecules expressed higher in endocardial vegetations were the LPXTG-
containing protein SasF, and the β-neurexin binding protein SdrC. Genes within the sdr 
region (sdrCDE) have been reported to be differentially transcribed [61], and sdr genes other 
than sdrC were not upregulated in endocardial vegetations. SdrC could mediate initial contact 
with host cells or cell adhesion molecules, such as β-neurexin [62], although our 
experimental endocarditis data indicate that it was not critical for the establishment of 
endocarditis. SdrC may play a role in complications of infectious endocarditis, such as 
metastatic seeding to neuronal tissues. 
The largest group of genes differentially expressed in vivo were involved in amino acid 
transport and metabolism. The chromosomal arginine deiminase pathway (arcABCD) was 
strongly upregulated in endocardial vegetations. Arginine metabolism may serve to counter 
acidification or serve as an energy source under anaerobic conditions [63]. The latter is 
supported by the fact that nitrate reductase (NirBD) and pyruvate formate lyase (PflAB, [64]) 
were also upregulated in endocardial vegetations. Expression of the superoxide dismutase 
gene sodA, which is induced under microaerophilic conditions [65], was reduced in 
endocardial vegetations. Although staphylococcal vegetations grow in the oxygen-rich 
bloodstream at the aortic valve, the microenvironment within the vegetation may be oxygen-
starved. Of note, we also observed differential gene expression of several gene clusters with 
yet unknown function (e.g. upregulation of SACOL2477 to SACOL2479 and downregulation 
of SACOL0157 to SACOL0160 in endocardial vegetations). Their role in staphylococcal 
infections and contribution to the pathogenesis of endocarditis in particular remains to be 
determined. 
S. aureus gene expression is controlled by a complex network of regulatory proteins. In a 
previous study, expression of S. aureus agr in rabbit endocardial vegetations was shown to 
increase over time and to correlate with bacterial densities in vegetations [66]. We observed 
that the agr operon was only consistently upregulated in endocardial vegetations from 
diabetic rats compared to cultures harvested from the logarithmic growth phase. The S. 
aureus fur regulator, which represses genes involved in iron acquisition, cytolysins, and 
immunomodulatory proteins [67], was also expressed lower in endocardial vegetations than 
in vitro, as was the transcriptional regulator sarS. Differential expression of other regulatory 
genes included down regulation of vraSR (involved in resistance to cell wall active antibiotics 
and antimicrobial peptides [68]) and the araC family regulator (linking environmental 
chemical signals and virulence factors [69]) and upregulation of the gluconate repressor 
operon gntR. The saeS gene was significantly down regulated in vivo in the vegetations of 
diabetic rats. 
With regard to genes differentially expressed in endocardial vegetations from diabetic and 
nondiabetic rats, we found 61 genes with higher expression levels in vegetations from 
diabetic animals. Although bacterial densities in the vegetations from both groups were 
similar (not shown), vegetations from diabetic animals were significantly larger and 
contained more bacteria than their nondiabetic counterparts. The composition or size of these 
vegetations may have an influence on staphylococcal gene expression in endocarditis. Of 
note, several of the differentially expressed genes with high upregulation (argG, argH, glyS, 
ureC) were previously reported to be upregulated in biofilms versus planktonic cultures [26]. 
Other genes found to be upregulated in diabetic vegetations (gapA, hemX, nrdF) were 
demonstrated to be under the control of glucose and CcpA [70]. In summary, we cannot 
exclude that differences in gene expression observed between diabetic and nondiabetic rats 
with endocarditis reflect differences in the size of the vegetations involved (possibly 
attributable to an altered innate immune response in diabetic hosts). However, there is also 
evidence that S. aureus may sense (and possibly benefit from) increased glucose levels in 
hosts with diabetes mellitus. 
Conclusions 
In summary, we have demonstrated that diabetes mellitus led to higher bacterial burdens in 
an experimental model of S. aureus endocarditis. Gene expression patterns in endocardial 
vegetations differed from those observed during in vitro growth with overall down regulation 
of transcription. Endocarditis promoted higher expression of genes encoding toxins, surface 
proteins, and enzymes involved in capsule biosynthesis, iron homeostasis, and glucose and 
amino acid metabolism. Our findings indicate that gene expression of the staphyloferrin B 
operon is upregulated in endocarditis, and that production of this siderophore promoted 
staphylococcal virulence in this infection model. These results may form a basis for future 
analyses of specific genes, regulators, and pathways that are critical in endocarditis and other 
infections. Our findings may thus contribute to a better understanding of S. aureus 
pathogenesis in vivo and lead to alternative approaches in prevention or treatment of 
staphylococcal endocarditis. 
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